Ardagh Metal Packaging vs Crown
AMBP and CCK side by side, both in fabricated metal products, except machinery and transportation equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AMBP and CCK compare
Ardagh Metal Packaging grew revenue faster over the last twelve months (12.0% versus 10.3% for Crown).
Crown keeps more of each dollar of sales as profit, with a net margin of 5.9% compared with 0.20% at Ardagh Metal Packaging.
Crown pays a dividend yielding 1.1%; Ardagh Metal Packaging does not pay one.
Crown scores higher on the StockData Score (19 against 4 for Ardagh Metal Packaging), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AMBP | CCK |
|---|---|---|
| Size and price | ||
| Market cap | – | $13.0B |
| Share price | $4.50 | $119.24 |
| Change, 1 year | 23.0% | 24.9% |
| Change, 5 years | −53.4% | 11.5% |
| Beta (5Y) | 0.99 | 0.66 |
| Employees | 6,500 | 23K |
| StockData Score | ||
| Total score | 4 | 19 (better) |
| Valuation score | 0 | 4 (better) |
| Growth score | 2 | 3 (better) |
| Performance score | 1 | 5 (better) |
| Health score | 1 | 3 (better) |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | – | 17.2× |
| P/S | – | 1.0× |
| P/B | – | 4.5× |
| EV/EBITDA | – | 11.6× |
| P/FCF | – | 10.8× |
| PEG | – | 8.07 |
| FCF yield | – | 9.2% |
| Fair value | – | $138.61 |
| Margin of safety | – | 14.0% |
| Growth | ||
| Revenue growth (TTM) | 12.0% (better) | 10.3% |
| Revenue growth, 5Y average | 9.8% (better) | 5.7% |
| Net income growth (TTM) | – | 40.8% |
| EPS growth (TTM) | – | 46.0% |
| EPS growth, 5Y average | – | 8.2% |
| Profitability | ||
| Gross margin | 12.4% | 21.0% (better) |
| Operating margin | 4.4% | 12.3% (better) |
| Net margin | 0.20% | 5.9% (better) |
| FCF margin | 5.0% | 9.0% (better) |
| Return on equity | – | 27.2% |
| Return on invested capital | 6.7% | 14.6% (better) |
| Financial health | ||
| Debt / equity | – | 2.11 |
| Net debt / EBITDA | 6.14 | 3.32 (better) |
| Interest coverage | – | 4.1× |
| Current ratio | 1.06 (better) | 1.05 |
| Altman Z-score | – | 1.99 |
| Piotroski F-score | 6 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 1.1% |
| Payout ratio | 2382% | 17.5% |
| Years of dividend growth | – | 4 |
| Buyback yield | – | 6.3% |
| Shareholder yield | – | 7.4% |
| Ownership | ||
| Held by institutions | 24.7% | 99.3% |
| Held by insiders | 76.1% | 0.96% |
| Insider net buying, 12 months | – | −$16.5M |
| Superinvestors holding | – | 3 |
| Short interest, % of float | 6.3% | 2.4% |
Go deeper
- AMBP stock overview
- AMBP income statement
- AMBP valuation and score
- CCK stock overview
- CCK income statement
- CCK valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.